Preclinical CRO Market: How Are Novel Modality Preclinical Requirements Creating New Market Segments?
Novel pharmaceutical modality preclinical services — the specialized preclinical testing requirements for mRNA therapies, gene therapy, cell therapy, oligonucleotide drugs, and CRISPR-based medicines creating distinct CRO capability requirements beyond traditional small molecule and monoclonal antibody testing — represent the fastest-growing and most technically demanding...
0 Комментарии 0 Поделились 9 Просмотры 0 предпросмотр